Quick Answer
Drugs Made In America Acquisition Corp. reported Total Assets of $550.8 thousand for the year ending 2024.
- This data is from Drugs Made In America Acquisition Corp.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
- XBRL data for this metric is available from 2024 to 2024 (1 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2024: $550.8 thousand | Q1 2025: $232.81 million | Q2 2025: $235.21 million | Q3 2025: $237.63 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: